Envisagenics
RNA Therapeutics Development
$25M Series B+ ·
Source: startupintros.com
Total raised: $45M across 3 sourced rounds
All 3 rounds ↓Signals
X account@envisagenics · created Dec 10, 2013 (12 years old) · 1,104 followers
Website registeredMar 28, 2013 (13 years old)
TIMELINE · MONEY RAISED
Envisagenics | 1830 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $25M | — | startupintros.com | |
| Series A | $19M | — | startupintros.com | |
| Seed | $1M | — | startupintros.com |
Timeline
- X account created
- Website created
Founders and team
MP
Maria Pineda CEO & Co-foundersource: envisagenics.comMA
Martin Akerman CTO & Co-founderLinkedIn · source: envisagenics.comSR
Sudhir Rao Chief Business Officer
Investors
BBristol-Myers Squibb
EEmpire State Development
MM12
MMadrona
NNational Cancer Institute
NNew York Ventures
RRed Cell Partners
TThird Kind Venture Capital
Similar Health and bio companies
VVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
AAraceli Biosciences$4.5M Seed · Nov 2026
PPhrontline Biopharma$40M Series A · Nov 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/envisagenics (get a free API key).